Clinical Trials in Israel

Israeli sites are very attractive for international, multicenter clinical trials. Hundreds of multinational and local clinical trials are performed every year, due to:

Key Opinion Leaders (KOL) – Israeli professionals are recognized worldwide. In fact, some of them serve as FDA advisors.
Highly experienced staff (sites/CROs), with more than 15 years ICH-GCP compliance.
The clinical trials regulatory and financial environments are very clear, and companies operating in Israel can provide clear guidance to clients from abroad on both the regulatory process and the financial guidelines.
The Israeli population is above the 7 Million, with a population density higher than 360/m2. Due to its high population density, the potential pool of patients is concentrated around major hospitals with modern facilities and equipment.

Primary Care in Israel

Israeli primary care is one of the more sophisticated systems worldwide. Israeli primary care advantages are:

Access to more than 7 Million people through 3 major providers.
All patient files digitalized. Feasibilities performed on real patient files within 72 hours.
Many excellence sites, more than 2,000 clinics and 100 pediatric clinics.
Sites within access to special populations, such as pediatrics, geriatric and disabled.
Easy process for multicenter trials 1 contract and 1 central IRB per provider.
Sites are audited on a regular basis by clients, MoH and other regulatory authorities.
More than 200 ICH-GCP trained, experienced investigators.

Learn more about performing clinical trials with TransCom: